Advertisement

Charcot Marie Tooth

  • Carly E. SiskindEmail author
Chapter

Abstract

Charcot–Marie–Tooth disease (CMT), or hereditary peripheral neuropathy, is the most common inherited neurological disease. CMT affects both motor and sensory nerves, causing difficulty walking due to foot drop and numbness, or neuropathic pain. The subtypes of CMTs vary by nerve conduction study and inheritance patterns. Multiple genes have been associated with CMT, and the different CMTs exhibit autosomal dominant, autosomal recessive, X-linked, and mitochondrial inheritance patterns. The most common form, CMT1A, is caused by a duplication of the PMP22 gene. Genetic counseling should address inter- and intra-familial phenotypic variability and discuss management issues.

Keywords

Genetic Testing Genetic Counselor Neuropathic Pain Nerve Conduction Study Compound Muscle Action Potential 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Supplementary material

Charcot–Marie–Tooth (CMT) (MOV 384472 kb)

References

  1. 1.
    Skre, H. (1974). Genetic and clinical aspects of Charcot-Marie-Tooth’s disease. Clinical Genetics, 6(2), 98–118.PubMedCrossRefGoogle Scholar
  2. 2.
    Saporta, A. S., Sottile, S. L., Miller, L. J., Feely, S. M., Siskind, C. E., & Shy, M. E. (2011). Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Annals of Neurology, 69(1), 22–33.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Sheth, S., Francies, K., Siskind, C. E., Feely, S. M., Lewis, R. A., & Shy, M. E. (2008). Diabetes mellitus exacerbates motor and sensory impairment in CMT1A. Journal of the Peripheral Nervous System, 13(4), 299–304.PubMedCrossRefGoogle Scholar
  4. 4.
    Feely, S. M. E., Laura, M., Siskind, C. E., Sottile, S., Davis, M., Gibbons, V. S., et al. (2011). MFN2 mutations cause severe phenotypes in most patients with CMT2A. Neurology, 76(20), 1690–1696.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Pitceathly, R. D., Murphy, S. M., Cottenie, E., Chalasani, A., Sweeney, M. G., Woodward, C., et al. (2012). Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease. Neurology, 79(11), 1145–1154.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Blair, I. P., Nash, J., Gordon, M. J., & Nicholson, G. A. (1996). Prevalence and origin of de novo duplications in Charcot-Marie-Tooth disease type 1A: First report of a de novo duplication with a maternal origin. American Journal of Human Genetics, 58(3), 472–476.PubMedCentralPubMedGoogle Scholar
  7. 7.
    Lewis, R. A., McDermott, M. P., Herrmann, D., Hoke, A., Clawson, L. L., Siskind, C., et al. (2013). High dose ascorbic acid treatment in CMT-1A: Results of a randomized double masked controlled trial. JAMA Neurology, 70(8), 981–987.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Micallef, J., Attarian, S., Dubourg, O., Gonnaud, P. M., Hogrel, J. Y., Stojkovic, T., et al. (2009). Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: A multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurology, 8(12), 1103–1110.CrossRefGoogle Scholar
  9. 9.
    Pareyson, D., Reilly, M. M., Schenone, A., Fabrizi, G. M., Cavallaro, T., Santoro, L., et al. (2011). Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): A double blind randomised trial. Lancet Neurology, 10(4), 320–328.PubMedCentralCrossRefGoogle Scholar
  10. 10.
    Shy, M. E., Siskind, C., Swan, E. R., Krajewski, K. M., Doherty, T., Fuerst, D. R., et al. (2007). CMT1X phenotypes represent loss of GJB1 gene function. Neurology, 68(11), 849–855.PubMedCrossRefGoogle Scholar
  11. 11.
    Shy, M. E., Chen, L., Swan, E. R., Taube, R., Krajewski, K. M., Herrmann, D., et al. (2008). Neuropathy progression in Charcot-Marie-Tooth disease type 1A. Neurology, 70(5), 378–383.PubMedCrossRefGoogle Scholar
  12. 12.
    Siskind, C. E., Murphy, S. M., Ovens, R., Polke, J., Reilly, M. M., & Shy, M. E. (2011). Phenotype expression in women with CMT1X. Journal of the Peripheral Nervous System, 16(2), 102–107.PubMedCrossRefGoogle Scholar
  13. 13.
    Siskind, C. E., & Shy, M. E. (2011). Genetics of neuropathies. Seminars in Neurology, 31(5), 494–505.PubMedCrossRefGoogle Scholar
  14. 14.
    Siskind, C. E., Panchal, S., Smith, C. O., Feely, S. M. E., Dalton, J. C., Schindler, A. B., et al. (2013). Genetic counseling for Charcot Marie Tooth disease (CMT). Journal of Genetic Counseling, 22(4), 422–436.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Stanford Hospital and Clinics Neuroscience CenterStanford UniversityStanfordUSA

Personalised recommendations